Igor Vorozhtsov, M.D. work email
- Valid
- Valid
- Valid
Igor Vorozhtsov, M.D. personal email
Igor Vorozhtsov, M.D. phone numbers
Life Sciences entrepreneur with international medical and big pharma background. Building high-performing businesses, partnerships, and teams across multiple therapeutic areas, funding channels, and geographies.
-
Founder And CeoRenaissance AestheticsRussia -
Founder & CeoRenaissance Aesthetics Jul 2023 - PresentMoscow, RussiaFrom the industry leading Motiva® implants and Mia® femtech to cutting-edge innovations in hemostasis and wound healing — we’re pioneering the world's breakthrough solutions in aesthetic medicine across & beyond the Eurasian Economic Union, leveraging our stellar medical education & commercial infrastructure. -
Managing PartnerMirpharm Group Of Pharmaceutical Companies Jan 2023 - Present -
Vp Global Business Development — Specialty & Rare DiseasesMirpharm Group Of Pharmaceutical Companies Jan 2020 - Jun 2023• Global expansion, in/out-licensing, orphan portfolio & pipeline development with its consequent commercialization• Identified, negotiated and executed several licensing and exclusive distribution deals across the US, Europe, MENA, LATAM, and APAC worth $50m+• Full P&L responsibility for Specialty & Rare Diseases BU with a cross-functional team incl. dedicated Sales & Marketing, Medical Affairs, Value Demonstration & Access, in close collaboration with Regulatory Affairs, Clinical Development and R&D -
Business Unit Director — Eye & Specialty CareAllergan Apr 2019 - Jan 2020Moscow, Russian Federation• P&L responsibility for a $20m diverse portfolio and team of 65 FTEs, incl. Sales & Marketing, Value Demonstration & Access, and Business Development across 3 merged BUs• Achieved sales targets and expanded funding across the board, with Ozurdex HTL inclusion and Botox Tx DRG breakthrough -
Business Unit Director — Internal Medicine, Immunology & OncologyShire Jan 2016 - Apr 2019Moscow, Russian Federation• Built a commercial organization of 32 FTEs from the ground up, incl. successful Baxalta integration, retaining the entire team:- developed 6 team members into Sales Management and Marketing roles, incl. 2 international President’s Club winners• Full P&L responsibility for a $0.3m ➝ $30m portfolio of 13 products, incl. 6 launches across 8 therapeutic areas:- consistently exceeded performance objectives and sales targets despite inherited stock, Gx pressure or transition periods- quadrupled Mezavant (IBD) market share (15%) with a tenfold growth in net revenue, followed by successful EDL inclusion- quadrupled Firazyr (HAE) sales with 87% patient share by improving diagnostics, access to therapy and utilization rates- defended 80% of Prothromplex sales at 2x price premium vs. biosimilars by creative differentiation in tenders• Led the country Business Development and key strategic innovation projects:- pioneered the Named Patient Access (import before registration) with the first Revestive ultra-rare patients ever funded across Eurasia, Middle East & Africa (EAMEA) — award for “Leadership in Short Bowel Syndrome awareness”- Award for “Leadership in New Launches Excellence” endorsed by the Head of EAMEA- JV with Generium: reimport of plasma-derived therapies fractionated in EU from plasma sourced in Russia- Oncaspar QA/Supply crisis resolution engaging the Parliament, Ministry of Health and Charity -
Director New Business DevelopmentShire May 2014 - Jan 2016Moscow, Russian Federation• Established Internal Medicine & Gastrointestinal BU with 5 new products, incl. 4 launches - each business case endorsed at the ILT and ExCo levels• Doubled Shire’s margin by negotiating & executing repatriation of several products from J&J• Expanded existing and set new distribution contracts, along with two localization projects -
Group Product DirectorThe Janssen Pharmaceutical Companies Of Johnson & Johnson Apr 2013 - May 2014Moscow, Russian Federation• $40m GI portfolio development, incl. a PPI blockbuster revival• «Best Marketer 2013-2014», «Gold Encore Award» for Pariet rebranding with an authentic integrated campaign driving double-digit Rx growth -
Product ManagerThe Janssen Pharmaceutical Companies Of Johnson & Johnson Dec 2011 - Apr 2013Moscow, Russian Federation• Launched two innovative GI products from scratch: “Encore Award” for the best launch NPS and top-of-mind awareness in the segment• Built lasting relations with the national GI community, as well as global KOLs in Neurogastromotility and Inflammatory Bowel Diseases -
Junior Product ManagerThe Janssen Pharmaceutical Companies Of Johnson & Johnson Dec 2010 - Nov 2011Moscow, Russian FederationPre-launch of two innovative GI products -
Medical Intern At UniversitätsklinikumUniversity Of Düsseldorf Aug 2009 - Sep 2009Düsseldorf Area, Germany -
Medical Intern At Rabin Medical CenterClalit Health Services Jul 2008 - Aug 2008Tel-Aviv, Israel -
Server And Memorabilia GuideHard Rock International Jun 2007 - Sep 2007Greater Boston Area
Igor Vorozhtsov, M.D. Education Details
-
Distinction -
Distinction
Frequently Asked Questions about Igor Vorozhtsov, M.D.
What company does Igor Vorozhtsov, M.D. work for?
Igor Vorozhtsov, M.D. works for Renaissance Aesthetics
What is Igor Vorozhtsov, M.D.'s role at the current company?
Igor Vorozhtsov, M.D.'s current role is Founder and CEO.
What is Igor Vorozhtsov, M.D.'s email address?
Igor Vorozhtsov, M.D.'s email address is js****@****ing.com
What is Igor Vorozhtsov, M.D.'s direct phone number?
Igor Vorozhtsov, M.D.'s direct phone number is +171734*****
What schools did Igor Vorozhtsov, M.D. attend?
Igor Vorozhtsov, M.D. attended Kazan State Medical University, University Of Exeter.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial